Clinical Trial Update: The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether triclosan-coated antibacterial sutures reduce the incidence of surgical site infection compared with standard sutures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• triclosan-coated sutures (triclosan-coated polyglactin 910 suture)

Snippet

Sponsor: Cairo University | Conditions: Surgical Site Infection | Phase 4 | Status: COMPLETED